Z. FINE, T. D. WOOD
94
REFERENCES
[1] M. Valko, D. Leibfritz, J. Moncol, M. T. Cronin, M.
Mazur and J. Telser, “Free Radicals and Antioxidants in
Normal Physiological Functions and Human Disease,”
International Journal of Biochemistry & Cell Biology,
Vol. 39, No. 1, 2007, pp. 44-84.
http://dx.doi.org/10.1016/j.biocel.2006.07.001
[2] H. Xu and M. Hepel, “Molecular Beacon-Based Fluores-
cent Assay for Selective Detection of Glutathione and
Cysteine,” Analytical Chemistry, Vol. 83, No. 3, 2011, pp.
813-819. http://dx.doi.org/10.1021/ac102850y
[3] M. Valko, H. Morris and M. T. Cronin, “Metals, Toxicity
and Oxidative Stress,” Current Medicinal Chemistry, Vol.
12, No. 10, 2005, pp. 1161-1208.
http://dx.doi.org/10.2174/0929867053764635
[4] W. Stricks and I. M. Koltoff, “Reactions between Mercu-
ric Mercury and Cysteine and Glutathione. Apparent
Dissociation Constants, Heats and Entropies of Formation
of Various Forms of Mercuric Mercapto-Cysteine and
-Glutathione,” Journal of the American Chemical Society,
Vol. 75, No. 22, 1953, pp. 5673-5681.
http://dx.doi.org/10.1021/ja01118a060
[5] B. J. Fuhr and D. L. Rabenstein, “Nuclear Magnetic Reso-
nance Studies of the Solution Chemistry of Metal Com-
plexes. IX. The Binding of Cadmium, Zinc, Lead, and
Mercury by Glutathione,” Journal of the American Chemi-
cal Society, Vol. 95, No. 21, 1973, pp. 6944-6950.
http://dx.doi.org/10.1021/ja00802a013
[6] R. K. Zalups, “Molecular Interactions with Mercury in
the Kidney,” Pharmacological Reviews, Vol. 52, 2000,
pp. 113-143.
[7] V. Mah and F. Jalilehvand, “Glutathione Complex For-
mation with Mercury(II) in Aqueous Solution at Physio-
logical pH,” Chemical Research in Toxicology, Vol. 23 ,
No. 11, 2010, pp. 1815-1823.
http://dx.doi.org/10.1021/tx100260e
[8] E. M. Krupp, B. F. Milne, A. Mestrot, A. A. Meharg and
J. Feldmann, “Investigation into Mercury Bound to Bio-
thiols: Structural Identification Using ESI-Ion-Trap MS
and Introduction of a Method for Their HPLC Separation
with Simultaneous Detection by ICP-MS and ESI-MS,”
Analytical and Bioanalytical Chemistry, Vol. 390, No. 7,
2008, pp. 1753-1764.
http://dx.doi.org/10.1007/s00216-008-1927-x
[9] F. M. Rubino, M. Pitton, G. Brambilla and A. Colombi,
“A Study of the Glutathione Metaboloma Peptides by
Energy-Resolved Mass Spectrometry as a Tool to Inves-
tigate into the Interference of Toxic Heavy Metals with
Their Metabolic Processes,” Journal of Mass Spectrome-
try, Vol. 41, No. 12, 2006, pp. 1578-1593.
http://dx.doi.org/10.1002/jms.1143
[10] N. Burford, M. D. Eelman and K. Groom, “Identification
of Complexes Containing Glutathione with As(III),
Sb(III), Cd(II), Hg(II), Tl(I), Pb(II) or Bi(III) by Elec-
trospray Ionization Mass Spectrometry,” Journal of In-
organic Biochemistry, Vol. 99, No. 10, 2005, pp. 1992-
1997. http://dx.doi.org/10.1016/j.jinorgbio.2005.06.019
[11] F. M. Rubino, C. Verduci, R. Giampiccolo, S. Pulvirenti,
G. Brambilla and A. Colombi, “Molecular Characteriza-
tion of Homo- and Heterodimeric Mercury(II)-Bis-
Thiolates of Some Biologically Relevant Thiols by Elec-
trospray Ionization and Triple Quadrupole Tandem Mass
Spectrometry,” Journal of the American Society for Mass
Spectrometry, Vol. 15, No. 3, 2004, pp. 288-300.
http://dx.doi.org/10.1016/j.jasms.2003.10.013
[12] S. J. James, P. Cutler, S. Melnyk, S. Jernigan, L. Janak, D.
W. Gaylor and J. A. Neubrander, “Metabolic Biomarkers
of Increased Oxidative Stress and Impaired Methylation
Capacity in Children with Autism,” American Journal of
Clinical Nutrition, Vol. 80, No. 6, 2004, pp. 1611-1617.
[13] J. Mutter, J. Naumann, R. Schneider, H. Wallach and B.
Haley, “Mercury and Autism: Accelerating Evidence?”
Neuro Endocrinology Letters, Vol. 26, 2005, pp. 439-446.
[14] T. W. Clarkson and L. Magos, “The Toxicology of Mer-
cury and Its Chemical Compounds,” Critical Reviews in
Toxicology, Vol. 36, No. 8, 2006, pp. 609-662.
http://dx.doi.org/10.1080/10408440600845619
[15] P. Caravatti and M. Allemann, “The Infinity Cell—A
New Trapped Ion Cell with Radiofrequency Covered
Trapping Electrodes for Fourier Transform Ion Cyclotron
Resonance Mass Spectrometry,” Organic Mass Spec-
trometry, Vol. 26, No. 5, 1991, pp. 514-518.
http://dx.doi.org/10.1002/oms.1210260527
[16] A. G. Marshall, C. L. Hendrickson and G. S. Jackson,
“Fourier Transform Ion Cyclotron Resonance Mass Spec-
trometry: A Primer,” Mass Spectrometry Reviews, Vol.
17, No. 1, 1998, pp. 1-35.
http://dx.doi.org/10.1002/(SICI)1098-2787(1998)17:1<1::
AID-MAS1>3.0.CO;2-K
[17] A. G. Harrison, “Ion Chemistry of Protonated Glutamic
Acid Derivatives,” International Journal of Mass Spec-
trometry, Vol. 210, 2001, pp. 361-370.
http://dx.doi.org/10.1016/S1387-3806(01)00405-5
[18] A. G. Harrison, “Fragmentation Reactions of Protonated
Peptides Containing Glutamine or Glutamic Acid,”
Journal of Mass Spectrometry, Vol. 38, No. 2, 2003, pp.
136-144. http://dx.doi.org/10.1002/jms.427
Open Access IJAMSC